Literature DB >> 6218813

A study of embolism in mitral valve disease and atrial fibrillation.

H A Dewar, D Weightman.   

Abstract

A number of possible risk factors, clinical, radiological, biochemical, and social have been examined in one group of 34 cases of mitral valve disease and four of lone atrial fibrillation, all of whom gave a history of embolism, and also in a group of 24 cases of mitral valve disease who gave no such history. All were on long-term anticoagulant treatment. Comparison of the two groups disclosed no features that would distinguish those who ran the greater risk of embolism from the remainder other than that the men in the former group were older and of shorter stature. At comparable age, the women with a history of embolism had smaller left atria. Examination of a special group of nine patients who had had embolism despite anticoagulant treatment also disclosed no special features, other than a greater age at the time of their first embolism. Fibrinolytic activity was less and the level of beta thromboglobulin was greater than normal in both groups. Those with proven risk of embolism were not distinguished by higher values of this platelet protein. Neither variable correlated with the type of heart disease. No positive association was found between cigarette smoking and the risk of embolism. Embolism was significantly more likely to occur between 0801 and 1600 hours than at other times of day.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6218813      PMCID: PMC481274          DOI: 10.1136/hrt.49.2.133

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  25 in total

1.  Smoking and fibrinolysis.

Authors:  L Janzon; I M Nilsson
Journal:  Circulation       Date:  1975-06       Impact factor: 29.690

2.  Fibrinolytic activity in the blood of 99 healthy young British, African and Asian subjects.

Authors:  I S Menon
Journal:  Lab Pract       Date:  1968-02

3.  Platelet survival in patients with rheumatic heart disease.

Authors:  P P Steele; H S Weily; H Davies; E Genton
Journal:  N Engl J Med       Date:  1974-03-07       Impact factor: 91.245

4.  Mitral valve disease, systemic embolism and anticoagulants.

Authors:  H A Fleming; S M Bailey
Journal:  Postgrad Med J       Date:  1971-09       Impact factor: 2.401

5.  Systemic embolism in mitral valve disease.

Authors:  N Coulshed; E J Epstein; C S McKendrick; R W Galloway; E Walker
Journal:  Br Heart J       Date:  1970-01

6.  Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material.

Authors:  H Aberg
Journal:  Acta Med Scand       Date:  1969-05

7.  The role of the lung in blood fibrinolysis.

Authors:  I S Menon; D Weightman; H A Dewar
Journal:  Clin Sci       Date:  1969-06       Impact factor: 6.124

8.  The release, distribution, and clearance of human beta-thromboglobulin and platelet factor 4.

Authors:  J Dawes; R C Smith; D S Pepper
Journal:  Thromb Res       Date:  1978-05       Impact factor: 3.944

9.  Three approaches to the radioimmunoassay of human beta-thromboglobulin.

Authors:  A E Bolton; C A Ludlam; S Moore; D S Pepper; J D Cash
Journal:  Br J Haematol       Date:  1976-06       Impact factor: 6.998

10.  Fibrinolysis in pulmonary hypertension.

Authors:  J M Goodhart; H A Dewar
Journal:  J Atheroscler Res       Date:  1967 Jan-Feb
View more
  2 in total

1.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Predictors of left atrial thrombus in mitral valve disease.

Authors:  G Davison; P Greenland
Journal:  J Gen Intern Med       Date:  1991 Mar-Apr       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.